Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Evidence of the usefulness of cardiac biomarkers in cancer patients has been available for more than 20 years, but only recently have guidelines emerged regarding their use.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Ky et al. (2013) studied this question.